Brain Cancer Resource Center
Patients with glioblastoma have very few treatment options to prolong survival; however, a new vaccine may change that.
Great strides have been made in cancer research this year, including targeted therapies that may soon be used as a standard of care.
Brain Cancer News
Glioblastoma typically has low survival rates, but targeted therapies and surgery may offer hope for some patients.
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|
Cancer Therapy Advisor Articles
- Non-Hodgkin Lymphoma (NHL) Treatment Regimens: Burkitt Lymphoma
- Non-Hodgkin Lymphoma (NHL) Treatment Regimens: AIDS-Related B-Cell Lymphoma
- Presenteeism May Be a Problem for Oncologists and, Ultimately, Their Patients
- Subcutaneous Trastuzumab May Be as Safe and Effective as Intravenous Formulation
- Researchers Identify Mechanism by Which NSAIDs Prevent Colon Cancer
- Cancer Surgery Cost Not Linked with Hospital Volume
- Ramucirumab Plus Pemetrexed and Platinum Chemotherapy Shows Clinical Activity in Advanced Nonsquamous NSCLC
- For Advanced Ewing Sarcoma, Olaparib Alone Not Effective
- High Rates of Overdetection of Recurrence of Prostate Cancer
- Androgen Deprivation Therapy in Men with Prostate Cancer and Increased Risk of Cardiovascular Events